Gastrointestinal cancers
Mechanisms linking obesity and gastrointestinal cancers
... for gastrointestinal cancers, including the pancreas, liver, esophagus, colorectum, stomach cardia and gallbladder [5] [6] [7] [8] [9] ...[10]. Cancers of the digestive tract account for ~25% of the ...
9
Perception of cancer in patients diagnosed with the most common gastrointestinal cancers
... The quality of life with the illness (in this case cancer) assessed by patients is strongly influenced by the accept- ance of this illness. Chronic diseases, associated with nu- merous limitations of many activities, may ...
11
HER3 over-expression and overall survival in gastrointestinal cancers
... Gastrointestinal cancers are a group of highly aggressive malignancies (primarily including gastric carcinoma and colorectal cancer) that constitute a major public health problem ...from ...
11
Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers
... In addition to the above results, the detection differences between CST4 and other biomarkers in the early stages (stage I and II) of GC and CRC are depicted in Table 5. Similar huge advantages in early diagnosis ...
14
Review Article Prognostic significance of long non-coding RNA AFAP1-AS1 in human gastrointestinal cancers: a meta-analysis
... In conclusion, our meta-analysis provides strong evidence that elevated AFAP1-AS1 ex- pression is associated with an unfavorable prognosis and advanced clinical progression in gastrointestinal cancers. ...
11
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
... Abstract: Angiogenesis is essential for cancer growth and metastasis. Vascular endothelial growth factor (VEGF) is a key modulator of angiogenesis. In addition, overexpression of VEGF is correlated with advanced disease ...
13
Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
... in gastrointestinal cancers, and especially in gastric ...in gastrointestinal cancer, and we will continue to research other possible causes of miR-148a expression regulation, such as SNP ...
11
<p>Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells</p>
... glucocorticoid receptor and upregulating glucose transporter 3 (GLUT3) and lactate dehydrogenase A (LDHA), two key glycolytic proteins 20 ; however, the effect of CUEDC2 on glycolysis in HCC cells has not been studied. ...
10
Matrix metalloproteinases and their inhibitors in the gastrointestinal cancers: current knowledge and clinical potential
... Carcinogenesis is a complex process during which cells undergo genetic and epigenetic alterations. Genetic poly- morphism is an important determinant of endogenous causes of cancer. Single nucleotide polymorphism (SNP) ...
11
Clinical Significance of Telomerase Activity in Peritoneal Disseminated Cells: Gastrointestinal Cancers
... of gastrointestinal (GI) cancers are ...GI cancers: 1 had premalignant disease, 2 had history of GI cancers, and 25 patients were clinically negative for ...of gastrointestinal ...
10
Contemporary enteral and parenteral nutrition before surgery for gastrointestinal cancers: a literature review
... Gastrointestinal cancers are among the most recognised oncological diseases in well-developed ...lower gastrointestinal tract with pancreatic cancer, liver can- cer and bile duct cancer ...
5
Impact of OCT4 and Its Related Signaling Pathways on Gastrointestinal Cancers: Focusing on Targeted Therapy
... various cancers including gastric, colorectal, lung, prostate, bladder, esophageal, breast cancer and diseases with cancer’s features have been noted and it is worth focusing on their CSCs ...Besides ...
15
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
... 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15–17) is the world-class conference co-sponsored by the American Society of Clinical Oncol- ogy, the American Society for Radiation ...
8
Prognostic value of miR-17-5 p in gastrointestinal cancers: a systematic review and meta-analysis
... with gastrointestinal cancers, including colorectal carcinoma, hepatocellular carcinoma, pancreatic carcinoma, gastric carcinoma, esophageal squamous cell car- cinoma, and ...
9
<p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>
... In comparison to preclinical studies, controversial results have been reported upon reviewing clinical studies. It is well known that yogurt and dairy products are a good source and rich in probiotics. 267 In this ...
35
Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series
... of cancers treated with im- munotherapy, none of the cases presented in this series met the criteria for pseudo-progression as subsequent imaging confirmed progressive ...
6
Original Article Enhanced expression of CD74 in gastrointestinal cancers and benign tissues
... these cancers has been suggested to be a prognostic factor with higher relative expression of CD74 behaving as a marker of tumor progression or poor clinical out- come ...the gastrointestinal system, their ...
12
Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes.
... of gastrointestinal (GI) tract are among the most deadly malignancies with a high mortality to incidence ...(CRC) cancers account for more than 2,894,000 deaths per annum ...colorectal cancers, a ...
42
Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis
... Methods: A systematic literature search of PubMed, Web of Science, Embase, Chinese National Knowledge Infrastructure, and WANFANG databases was conducted to identify the related studies published before May 1, 2015, ...
8
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
... metastatic gastrointestinal cancer patients, and show examples of how these cancer organoids can be used to compare drug responses to those of the actual ...
25